Problems
Surface‑level discovery no longer differentiates
Buyers don’t show up blank anymore. In most categories, they arrive with pre‑work done, short lists formed, and internal hypotheses already circulating. Research finds buying groups are ~70% through their process before speaking with sales, 80% of first contacts are buyer‑initiated, and 81% of buyers already have a preferred vendor when the conversation starts. That means the sponsor’s initial framing is often polished, but incomplete—and you’re already competing with an internal narrative. 6sense Buyer Experience 2024
Layer‑one discovery still matters, but it mostly surfaces symptoms. Differentiation now comes from diagnosing causes: the organizational and systemic conditions generating those symptoms. As deals progress and more functions weigh in (finance, legal, security, executives), priorities necessarily shift; Forrester shows an average of ~13 stakeholders, 89% of purchases cross departments, and 86% of deals stall at some point, usually when unexamined constraints emerge. Forrester: State of Business Buying 2024
Implication: winning reps no longer “discover pain” as the finish line; they diagnose constraints as the difference‑maker.
Superficial discovery slows deals and erodes credibility
When sellers accept the first explanation at face value, four predictable things happen:
The proposed solution addresses only part of the constraint. Late‑stage stakeholders (CFO, Legal) introduce new decision criteria—CFOs often hold final decision power (79%), while 61% of legal teams slow or block purchases—forcing painful re‑work. G2 Buyer Behavior 2024 – Business Wire summary
Champions lack a defensible narrative across the committee. With journeys spanning ~10 channels, more than half of buyers will switch suppliers if the cross‑channel experience is clumsy; internally, a clumsy decision narrative triggers confusion and churn. McKinsey B2B Pulse 2024
Objections surface late around risk, governance, or integration because root causes were never discussed—consistent with Forrester’s broad stall rates. Forrester 2024
Competitors reframe the problem, resetting evaluation criteria and stealing momentum.
Net effect: deals slow or stall not due to product gaps, but because the seller optimized for the symptom the buyer described, not the system producing it.
Elite reps use a two‑layer diagnostic model
Top performers consistently map issues in two layers:
Layer 1 — The Stated Problem (symptom): long cycle times, low conversion, slow approvals, reporting gaps.
Layer 2 — The Real Constraint (mechanism): unclear decision rights, misaligned incentives, data fragmentation, undocumented workflows, resource bottlenecks, outdated risk thresholds.
They treat the first layer as the entry point, not the destination—then earn authority by explaining how the system generates the symptom.
This mindset aligns with well‑documented decision dynamics. Under pressure, organizations privilege safe narratives and suppress deeper discussion; psychological‑safety research shows teams under scrutiny struggle to explore root causes, defaulting to surface fixes. Edmondson, Administrative Science Quarterly
The mindsets that enable deeper diagnosis
1) Assume the first answer is incomplete.
Treat stated pain as a hypothesis, not the truth. Buying groups routinely update preferences as context changes; plan for that evolution. Forrester 2024
2) Look for patterns, not incidents.
One missed quarter or one slow approval is an event; five similar cases across teams signal a mechanism. Multi‑channel complexity (≈10 touchpoints) guarantees multiple failure points—pattern‑spotting matters. McKinsey 2024
3) Explore organizational fault lines.
Decision rights, budget ownership, and risk tolerance often sit in different departments; late CFO/Legal influence is common, so probe how decisions really move. G2 2024 – Business Wire
4) Pressure‑test without confrontation.
Questions that normalize ambiguity invite candor even in low‑safety environments, avoiding the defensiveness Edmondson warns about. (Edmondson 1999
5) Map consequences beyond one persona.
A sales “speed” problem might be a finance risk problem (thresholds), a security problem (data lineage), or a legal problem (approval scope). Forrester 2024
A five‑step framework to find the problem behind the problem
Step 1: Capture the stated problem precisely
Document the buyer’s words, metrics, and context.
“We’re losing late‑stage deals because pricing approvals are too slow.”
This frames the symptom, not yet the system.
Step 2: Ask a structural clarifier
Probe the environment around the event rather than the event itself:
“How is the approval workflow defined today?”
“Who owns a delay when it occurs?”
“When it works, what conditions are present? When it fails, what changed upstream?”
These flip the lens from episode to ecosystem, which is crucial when ~13 stakeholders and cross‑departmental handoffs are the norm. Forrester 2024
Step 3: Identify the hidden constraint
Most recurring symptoms map to repeatable categories:
Process ambiguity: unclear steps/owners.
Resource scarcity: not enough people/time/tools.
Coordination gaps: cross‑functional misalignment.
Decision complexity: too many approvers or fuzzy criteria.
Data fragmentation: conflicting or missing inputs.
Incentive misalignment: goals at odds across teams.
Expect friction to widen as more channels and reviewers join—omnichannel complexity makes latent constraints visible. McKinsey 2024
Step 4: Test for organizational impact
Connect the constraint to broader consequences:
Slow approvals → unclear risk thresholds (finance), inconsistent data lineage (security), or outdated authority matrices (legal).
This is where late‑stage stalls happen; CFO/Legal will probe these even if the champion didn’t. G2 2024 – Business Wire
Step 5: Reframe collaboratively
Offer a higher‑fidelity problem statement the champion can carry internally:
“Approval speed looks like the symptom; the constraint appears to be misaligned decision criteria across finance, product, and sales. If we align thresholds and owners upstream, approvals become faster and predictable.”
This equips the champion for a committee that spans ~10 channels and multiple departments. McKinsey 2024
What this changes for sellers and teams
1) Better discovery improves win probability.
Surfacing constraints early reduces the stall risk (86%) Forrester flags, because late‑stage reviewers see their concerns addressed. Forrester 2024
2) Champions gain internal influence.
They carry a narrative that resonates with CFO/Legal/Exec expectations. Public review sites are the most consulted source and 57% of buyers expect ROI ≤ 3 months; arming sponsors with CFO‑grade proof and clear governance increases credibility. G2 2024
3) Deal risk decreases.
By tying symptoms to mechanisms, you pre‑empt objections that typically surface under omnichannel scrutiny. McKinsey 2024
4) The evaluation framework shifts.
Reframing upstream constraints influences how success is defined across the buying group. Forrester 2024
5) Reps become advisors, not vendors.
In crowded markets, the advisory layer is the differentiator buyers remember before they contact sales and after they compare vendors. 6sense 2024
Illustrative mini‑case
An ops sponsor blamed slow pricing approvals for late‑stage losses. Initial discovery focused on workflow speed. The rep then ran the two‑layer model: they mapped the approval ecosystem and found mismatched risk thresholds between Finance and Sales plus missing audit logs for Legal. The reframed initiative aligned thresholds, added standardized logs, and implemented a time‑boxed pilot to validate both speed and defensibility—meeting omnichannel and CFO/Legal expectations. The champion’s internal memo won quick alignment; the deal advanced without stall. ([G2 2024 – Business Wire](; McKinsey 2024 [everstage.com]
Actionable takeaways
Treat the buyer’s first problem statement as a starting point. Forrester 2024
Ask structural questions that examine the system, not just the event. McKinsey 2024
Map the symptom to a hidden constraint category; expect CFO/Legal scrutiny. G2 2024
Tie the deeper problem to organization‑wide impact to pre‑empt stalls. Forrester 2024
Reframe collaboratively so your champion can carry a defensible, cross‑functional narrative. McKinsey 2024
Elite reps win because they diagnose what others overlook. They don’t just fix the problem the buyer describes; they fix the problem the business actually faces—and they prove it in a way committees can defend.
